Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105026
Filing Date
2025-08-07
Accepted
2025-08-07 16:11:36
Documents
72
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bdsx-20250630.htm   iXBRL 10-Q 2522133
2 EX-31.1 bdsx-ex31_1.htm EX-31.1 15990
3 EX-31.2 bdsx-ex31_2.htm EX-31.2 16008
4 EX-32.1 bdsx-ex32_1.htm EX-32.1 9056
5 EX-32.2 bdsx-ex32_2.htm EX-32.2 9281
  Complete submission text file 0000950170-25-105026.txt   11281911

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bdsx-20250630.xsd EX-101.SCH 1840874
75 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20250630_htm.xml XML 1950066
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39659 | Film No.: 251194112
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)